Proteome Sciences (CHIX:PRML) Cash per Share: £0.00 (As of Dec. 2025)

What is Proteome Sciences Cash per Share?

Proteome Sciences CHIX:PRML +7.63% Cash per Share is £0.00 as of Dec. 2025. The stock has 6 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Proteome Sciences's Cash per Share for the quarter that ended in Dec. 2025 was £0.00.

Proteome Sciences (CHIX:PRMl) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Proteome Sciences Cash per Share Related Terms

Proteome Sciences Cash per Share Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences Cash per Share Chart

Proteome Sciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

0.01

0.00

Proteome Sciences Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Cash per Share	Get a 7-Day Free Trial															0.01	0.00	0.00	0.00	0.00

Proteome Sciences Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Proteome Sciences's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.781	/	295.18
	=	0.00

Proteome Sciences's Cash per Share for the quarter that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	0.781	/	295.18
	=	0.00

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of £0.00 mean?

Proteome Sciences (CHIX:PRML) has a Cash per Share of £0.00 as of Dec. 2025. Cash per share is the per-share value of a company's available cash. View historical data for Proteome Sciences and its competitors.

Is Proteome Sciences' Cash per Share too high?

Proteome Sciences' current Cash per Share is £0.00.

How does Proteome Sciences' Cash per Share compare to TMO and DHR?

Proteome Sciences' Cash per Share of £0.00 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Medical Diagnostics & Research company?

A good Cash per Share depends on the Medical Diagnostics & Research industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Proteome Sciences and its competitors. Proteome Sciences's current Cash per Share is £0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Proteome Sciences stock overvalued right now?

Based on GuruFocus' analysis, Proteome Sciences (CHIX:PRML) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 29.5% below its estimated fair value. The current Cash per Share is £0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Proteome Sciences (CHIX:PRML), the current Cash per Share is £0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies LSE:OBD LSE:GENI LSE:VRCI LSE:GDR LSE:ABDX LSE:CLBX TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH

Other Exchanges PRM:UK PI2:Germany

Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP

Website https://www.proteomics.com

Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.